BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection

BACKGROUND: Despite major advances in the management of metastatic colorectal cancer (mCRC) with liver-only involvement, relapse rates are high and reliable prognostic markers are needed. METHODS: To assess the prognostic impact of BRAF and RAS mutations in a large series of liver-resected patients,...

Descripción completa

Detalles Bibliográficos
Autores principales: Schirripa, M, Bergamo, F, Cremolini, C, Casagrande, M, Lonardi, S, Aprile, G, Yang, D, Marmorino, F, Pasquini, G, Sensi, E, Lupi, C, De Maglio, G, Borrelli, N, Pizzolitto, S, Fasola, G, Bertorelle, R, Rugge, M, Fontanini, G, Zagonel, V, Loupakis, F, Falcone, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580391/
https://www.ncbi.nlm.nih.gov/pubmed/25942399
http://dx.doi.org/10.1038/bjc.2015.142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580391/
https://www.ncbi.nlm.nih.gov/pubmed/25942399
http://dx.doi.org/10.1038/bjc.2015.142

Ejemplares similares